Although meningococcemia remains an important concern when evaluating a child with fever and a rash, the resurgence of measles, the emergence of invasive group A streptococcal disease and antibiotic-resistant Staphylococcus aureus, as well as the fear of agents of bioterrorism (anthrax, smallpox) have changed the landscape of fever and rash in the 21st century.
In our opinion, it was not the case, because the way of diagnosing VAP remains the same, based on radiological findings, the occurrence of fever, change in leukocytosis and bacteriological results.
The mechanism of ST segment changes in the setting of fever is likely secondary to further compromise of INa due to accelerated inactivation of the channel with higher body temperature, 155 or reduced channel conductance.
Routine chemical CSF analysis in patients with external drains included daily evaluation of cell count, protein, glucose and lactate concentrations, as well as microbiological culture in case of fever, changes in CSF chemistry and unclear neurological deterioration.
To assess the effect of expected seasonal changes on the incidence of fever, the incidence in risk and control windows in the year with the campaign was compared to pseudo-risk and control windows of the same month and days in the off-campaign year and estimated a ratio of IRRs (RIRR) [ 17].
Clinically a case of AES is defined as fever or recent history of fever with change in mental status (including confusion, disorientation, coma, or inability to talk) and/or new onset of seizures (excluding simple febrile seizures).
Cases definitions were as follows: AES: Fever or recent history of fever with change in mental status (including confusion, disorientation, coma, or inability to talk) and/or new onset of seizures (excluding simple febrile seizures).
An AMES case-patient was defined as a person of any age who experienced acute onset of fever with change in mental status and/or meningeal signs (e.g., neck stiffness, headache).
Patients receiving mechanical ventilation (MV) for ≥96 hours and who developed suspected VAP (new or worsening pulmonary opacities on CXR, and at least two of fever, leukocytosis, change in sputum purulence, increased O2 needs, or isolation of potentially pathogenic bacteria from sputum) were eligible.
A medical epidemiologist reviewed the output on a daily basis, and noted any changes to community-wide incidences of fever.
